Skip to main content

Table 1 NADH:quinone oxidoreductase activity in control and transfected cells

From: Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls

Cell line

NADH:quinone oxidoreductase specific activity w/o rotenone (nmol/min/mg Prot)

NADH:quinone oxidoreductase specific activity with rotenone (nmol/min/mg Prot)

Inhibition (%)

NHDF

7.7 (±0.5)

1.7 (±0.2)

78.3%

79,787

2.5 (±0.2)

1.4 (±0.1)

42.6%

79,787-T-ScNDI1

24.0 (±8.7)

20.7 (±8.3)

13.7%

79,787-T-AtNDB4

11.8 (±2.4)

10.6 (±1.9)

10.0%

79,787-T-ATNDA2

5.3 (±0.9)

5.3 (±0.9)

2.7%

  1. Spectrophotometric assessment of NADH:quinone oxidoreductase specific activity in control cells (NDHF) and NDUFS4 cell line untransfected (79787) and transfected with alternative NADH oxidases (ScNDI1, AtNDA2 and AtNDB4). Values are expressed as mean ± SD